Dongwha Pharm.Co.,Ltd (KRX: 000020)

Dongwha Pharm.Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	42,149	72,317	34,347	60,480	58,596	37,779
Short-Term Investments	10,636	7,264	47,820	54,800	55,100	79,220
Trading Asset Securities	9,279	9,249	25,527	6,230	6,634	3,020
Cash & Short-Term Investments	62,064	88,830	107,695	121,510	120,331	120,019
Cash Growth	-39.07%	-17.52%	-11.37%	0.98%	0.26%	15.77%
Accounts Receivable	72,576	64,745	61,194	56,291	57,697	70,625
Other Receivables	13,805	9,622	5,491	4,803	4,052	9,523
Receivables	86,380	74,368	66,795	61,093	61,752	80,151
Inventory	73,192	70,697	46,784	36,244	39,504	33,431
Prepaid Expenses	1,777	1,912	843.38	403.11	292.91	891.68
Other Current Assets	3,146	1,893	5,411	948.43	863.85	964.43
Total Current Assets	226,560	237,700	227,527	220,199	222,743	235,457
Property, Plant & Equipment	196,757	188,330	151,153	142,851	130,951	99,215
Long-Term Investments	68,195	72,647	54,847	50,616	48,774	29,277
Goodwill	20,483	20,483	4,556	4,556	4,556	-
Other Intangible Assets	35,857	35,995	11,147	13,582	12,417	5,465
Long-Term Deferred Tax Assets	7,115	6,242	6,400	6,194	3,966	5,981
Other Long-Term Assets	3,742	3,575	5,507	9,807	10,401	962.82
Total Assets	558,709	564,972	461,136	447,804	433,808	376,357
Accounts Payable	31,496	31,412	22,232	17,119	18,522	17,323
Accrued Expenses	11,979	13,601	12,032	10,445	9,085	8,777
Short-Term Debt	6,418	14,670	2,500	4,500	9,800	-
Current Portion of Leases	4,869	4,547	2,120	1,918	1,814	1,793
Current Income Taxes Payable	3,833	2,224	2,932	4,481	6,234	6,473
Current Unearned Revenue	-	4.67	-	-	-	-
Other Current Liabilities	36,745	38,520	32,592	26,843	20,885	21,349
Total Current Liabilities	95,340	104,980	74,408	65,307	66,340	55,715
Long-Term Debt	16,000	16,128	477.13	3,460	-	-
Long-Term Leases	11,765	11,756	1,567	1,596	4,075	5,116
Long-Term Unearned Revenue	-	-	22.87	40.47	-	-
Long-Term Deferred Tax Liabilities	6,742	6,772	2,096	2,703	2,476	-
Other Long-Term Liabilities	13,394	13,013	2,664	2,892	2,723	2,042
Total Liabilities	148,495	156,762	81,309	86,517	89,971	76,649
Common Stock	27,931	27,931	27,931	27,931	27,931	27,931
Additional Paid-In Capital	17,757	17,757	27,545	27,545	27,069	27,069
Retained Earnings	294,488	292,251	274,356	252,712	232,628	207,945
Treasury Stock	-1,663	-1,663	-1,965	-1,965	-2,521	-2,521
Comprensive Income & Other	35,478	35,503	36,534	40,712	46,148	39,284
Total Common Equity	373,991	371,780	364,400	346,935	331,256	299,708
Minority Interest	35,069	35,277	14,273	13,198	11,427	-
Shareholders' Equity	410,214	408,211	379,828	361,288	343,837	299,708
Total Liabilities & Equity	558,709	564,972	461,136	447,804	433,808	376,357
Total Debt	39,052	47,101	6,664	11,474	15,689	6,909
Net Cash (Debt)	23,012	41,729	101,031	110,036	104,642	113,110
Net Cash Growth	-76.12%	-58.70%	-8.18%	5.15%	-7.49%	9.11%
Net Cash Per Share	830.62	1507.25	3650.06	3981.90	3788.46	4097.03
Filing Date Shares Outstanding	27.72	27.72	27.68	27.68	27.61	27.61
Total Common Shares Outstanding	27.72	27.72	27.68	27.68	27.61	27.61
Working Capital	131,220	132,721	153,119	154,892	156,404	179,742
Book Value Per Share	13492.75	13412.96	13165.17	12534.17	11998.65	10855.96
Tangible Book Value	317,651	315,302	348,698	328,797	314,283	294,244
Tangible Book Value Per Share	11460.13	11375.37	12597.87	11878.87	11383.87	10658.02
Land	60,650	60,720	58,691	59,118	56,062	29,771
Buildings	116,919	116,422	110,623	111,571	111,573	106,232
Machinery	115,485	113,504	98,257	93,686	87,590	75,726
Construction In Progress	43,982	33,906	23,896	13,628	4,983	1,229

Source: S&P Capital IQ. Standard template. Financial Sources.